Evaluation of the role of injection therapy for benign prostatic hypertrophy.
Intraprostatic phenol injection treatment was given to 13 cases of benign prostatic hypertrophy (BPH) without urinary retention. Symptomatic improvement was significant, although objective assessment showed neither significant alteration in the size of the prostate nor in the urinary flow rate. Injection therapy is considered inadequate in the relief of prostatic obstruction.
D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D010636:Phenols / Q000627:therapeutic use*; D011467:Prostate / Q000473:pathology; D011470:Prostatic Hyperplasia / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D014563:Urodynamics
D010636:Phenols